aTyr Pharma, Inc.ATYRNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank62
5Y CAGR-14.7%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-14.7%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 10.29% |
| 2024 | -84.81% |
| 2023 | 13.99% |
| 2022 | -30.84% |
| 2021 | -114.58% |
| 2020 | 22.84% |
| 2019 | 36.53% |
| 2018 | 27.52% |
| 2017 | 18.30% |
| 2016 | -42.71% |